TITLE

Flying and cystic fibrosis: getting there and back safely

AUTHOR(S)
Webb, A. K.
PUB. DATE
November 2001
SOURCE
Thorax;Nov2001, Vol. 56 Issue 11, p821
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article is a timely evaluation of the pre-flight hypoxic challenge in children with cystic fibrosis. Patients with cystic fibrosis have the same expectations as their healthy peers and this includes holidays abroad with family and friends to far away places which require long haul flights. This expectation is irrespective of the severity of their disease. The physician has the responsibility of balancing their wish to enjoy themselves against their medical safety. The risk of flying is related to the fact that barometric pressure reduces with altitude.
ACCESSION #
12915309

 

Related Articles

  • Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique . C Guilbault; P Martin; D Houle; M-L Boghdady; M-C Guiot; D Marion; D Radzioch // Laboratory Animals;Jun2005, Vol. 39 Issue 3, p336 

    To better understand the mechanism of lung infection with Pseudomonas aeruginosa (P. aeruginosa), many techniques have been developed in order to establish lung infection in rodents. A model of chronic lung infection, using tracheotomy to inoculate the bacteria, has been extensively used in the...

  • Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report. Levy, Hara; Cannon, Carolynn L.; Asher, Daniel; García, Christopher; Cleveland, Robert H.; Pier, Gerald B.; Knowles, Michael R.; Colin, Andrew A.; García, Christopher // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Mutations in both alleles of the cystic fibrosis transmembrane conductance regulator gene result in the disease cystic fibrosis, which usually manifests as chronic sinopulmonary disease, pancreatic insufficiency, elevated sodium chloride loss in sweat, infertility...

  • Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. Baumer J H // Archives of Disease in Childhood;Dec2003, Vol. 88 Issue 12, p1126 

    A well produced evidence based guideline has been developed in response to a national audit that demonstrated wide variations in the performance of sweat tests. Accurate and reliable sweat test results will be particularly important with the advent of neonatal screening. The guideline...

  • Andy versus Cystic Fibrosis. Lipman, Eva // Exceptional Parent;Nov2003, Vol. 33 Issue 11, p30 

    Recounts a mother's struggle in raising up a child with cystic fibrosis (CF). Clinical manifestations and epidemiology of the disease; Symptoms observed in Andy Lipman, the second born child of Charles and Eva Lipman with CF; Fears and excitement felt by the parents on the birth of Andy:...

  • An Unexpected Reprieve. Whitford, Ben // Newsweek (Pacific Edition);9/12/2005 (Pacific Edition), Vol. 146 Issue 11, p48 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

  • An Unexpected Reprieve. Whitford, Ben // Newsweek (Atlantic Edition);9/12/2005 (Atlantic Edition), Vol. 146 Issue 11, p54 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

  • An Unexpected Reprieve. Whitford, Ben // Newsweek;9/12/2005, Vol. 146 Issue 11, p64 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

  • Myeloperoxidase Promoter Polymorphism -463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease. Reynolds, Wanda F.; Sermet-Gaudelus, Isabelle; Gausson, Val�rie; Feuillet, Marie-No�lle; Bonnefont, Jean-Paul; Lenoir, G�rard; Descamps-Latscha, B�atrice; Witko-Sarsat, V�ronique // Mediators of Inflammation;4/1/2006, Vol. 2006 Issue 2, p1 

    The severity of cystic fibrosis (CF) pulmonary disease is not directly related to CFTR genotype but depends upon several parameters, including neutrophil-dominated inflammation. Identification of agents modulating inflammation constitutes a relevant goal. Myeloperoxidase (MPO) is involved in...

  • Establishing a diagnosis of cystic fibrosis. Southern, KW; Peckham, D // Chronic Respiratory Disease;2004, Vol. 1 Issue 4, p205 

    Cystic fibrosis (CF) is a recessively inherited condition caused by mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Characterization of the genetic defect has improved understanding of the condition and, in the majority of cases, diagnosis is straightforward....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics